期刊文献+

糖尿病肾病患者尿胱抑素C和α1-微球蛋白水平变化研究 被引量:2

Research on changes of urinary cystatin C and α1-microglobulin in diabetic nephropathy patients
下载PDF
导出
摘要 目的:研究糖尿病肾病患者尿胱抑素C(CysC)和α1-微球蛋白(α1-MG)水平变化。方法:选取我院2012年7月-2014年7月糖尿病肾病患者52例和单纯糖尿病患者40例,其中糖尿病肾病分为微量白蛋白尿亚组24例和临床蛋白尿亚组28例,再选取同期于我院体检的健康人40例设置为对照组,比较各组血清CysC、α1-MG和尿CysC、α1-MG的水平及异常率。结果:糖尿病肾病组患者血清CysC、α1-MG及尿CysC、α1-MG水平较对照组和单纯糖尿病组显著较高(P<0.05);微量清蛋白尿亚组血清CysC、α1-MG及尿CysC、α1-MG水平较临床蛋白尿亚组显著较低(P<0.05);糖尿病肾病组CysC、α1-MG及尿CysC、α1-MG异常率显著高于对照组和单纯糖尿病组(P<0.05)。结论:糖尿病肾病患者尿CysC和α1-MG水平较单纯糖尿病患者及对照组显著较高,在糖尿病肾病的早期诊断中具有重要的临床价值,值得应用推广。 Objective:To study the changes of urinary cystatin C andα1-microglobulin in patients with diabetic nephropathy.Methods:52patients with diabetic nephropathy and40patients with diabetes mellitus were selected from July2012to July2014.Patientswith diabetic nephropathy were divided into the microalbuminuria group(24cases)and clinical proteinuria group(28cases).40casesof healthy people in our hospital were selected as the control group,and the levels of serum Cys C,α1-MG and urinary Cys C andα1-MG were compared.Results:The levels of serum Cys C,α1-MG and urinary Cys C andα1-MG in the diabetic nephropathy group weresignificantly higher(P<0.05).The abnormal rate of Cys C,α1-MG and urinary Cys C andα1-MG in diabetic nephropathy group weresignificantly higher(P<0.05),and the level of urinary Cys C andα1-MG was significantly lower(P<0.05).Conclusion:The levels ofurinary Cys C andα1-MG in patients with diabetic nephropathy are significantly higher than those in patients with diabetes mellitus andhealthy people.
作者 周明欣
机构地区 高州市中医院
出处 《中医临床研究》 2017年第13期134-136,共3页 Clinical Journal Of Chinese Medicine
关键词 糖尿病肾病 胱抑素C 尿Α1-微球蛋白 Diabetic nephropathy Cystatin C Urinary α1-microglobulin
  • 相关文献

参考文献6

二级参考文献98

  • 1Tanuj Chawla,Deepika Sharma,Archana Singh.Role of the renin angiotensin system in diabetic nephropathy[J].World Journal of Diabetes,2010,1(5):141-145. 被引量:34
  • 2刘慧丽,袁立,杨云青.醛糖还原酶遗传缺失可显著减缓C57BL/6小鼠糖尿病肾病进程[J].中华糖尿病杂志,2010,2(5). 被引量:5
  • 3谈力欣,王战建.肥胖与糖尿病肾病的发病机制[J].中华糖尿病杂志,2010,2(5). 被引量:2
  • 4马清光,张昕明,刘晓黎,李梅轻,李小刚.四种方法尿微量白蛋白排出率对糖尿病肾病早期诊断价值评价[J].中国实验诊断学,2007,11(3):327-329. 被引量:8
  • 5Yokoyama M, Tanigawa K, Murata T, et al. Dietary polyunsaturated fatty acids slow the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Nutr Res, 2010, 30: 217- 225.
  • 6Kuwabara T, Mori K, Mukoyama M, et al, Exacerbation of diabetic nephropathy by hyperlipidaemiais mediated by Toll- like receptor 4 in mice. Diabetologia, 2012, 55: 2256-2266.
  • 7Campbell KN, Rai JL, Mundel P. Role of anglotensin 11 in the development of nephropathy and podocytopathy of diabetes. Curt Diabetes Rev, 2011, 7: 3-7.
  • 8Kumar PA, Brosius FC 3rd, Menon RK. The glomerular podocyte as a target of growth hormone action:implications for the pathogenesis of diabetic nephropathy. Curr Diabetes Rev, 2011, 7: 50-55.
  • 9Romero M, Ortega A, Izquierdo A, et al. Parathyroid hormone- related protein induces hypertrophy in podocytes via TGF-beta (1) and p27(Kipl): implications for diabetic nephropathy. Nephrol Dial Transplant, 2010, 25: 2447-2457.
  • 10Nagase R, Kajitani N, Shikata K, et al. Phenotypic change of macrophages in the progression of diabetic nephropathy; sialoadhesin- positive activated macrophages are increased in diabetic kidney. Clin Exp Nephrol, 2012, 16: 739-748.

共引文献422

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部